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Comments on "Why Not Use
It All?"
The recent editorial by George Lucier (1)
mischaracterizes the two key aspects ofthe
Society of Toxicology (SOT)-European
Society of Toxicology (EUROTOX)
debate, which was a part ofthe program of
the March 1999 SOT Annual Meeting
held in New Orleans, Louisiana. First, the
debaters represented neither an SOT
motion nor a EUROTOX motion, i.e., this
is not a situation where the two societies
have taken an official position on an issue.
Second, the debate was not intended to
persuade the audience to simply accept one
side and jettison the data presented by the
other side. The SOT-EUROTOX debate
provides a public forum for airing different
viewpoints and differences in interpretation
of data surrounding a scientific issue. It is
framed deliberately in a provocative fashion
to stimulate an open, thorough discussion.
This type ofdiscussion facilitates introspec-
tion and leads to an enhanced understand-
ing ofthe issue at hand.
The particular debate in question
focused upon the following hypothetical
motion: "The Results of Mechanistic
Toxicity Studies Should Supersede
Ambiguous Epidemiological Data." This
debate was a part ofan annual cooperative
activity between two of the largest profes-
sional organizations of toxicologists in the
world: the SOT and EUROTOX. A topic
chosen jointly by the program committee
of each society is debated at each society's
annual meeting, the SOT meeting in
March and the EUROTOX meeting in
June. The two program committees select
a member oftheir respective society to par-
ticipate in the debate, and the same indi-
viduals debate the issue in the United
States and in Europe. In addition to select-
ing a new topic and new debaters each
year, the "side" that each society takes
changes yearly, i.e., in even-numbered
years EUROTOX speaks for the motion
and SOT speaks against it, whereas the
SOT speaks for the motion and EURO-
TOX against it in odd-number years.
Importantly, the topic does not represent
an official position of either society.
Rather, a considered extreme "pro" and
"con" side of the issue is set initially to
force each side to marshal their best ratio-
nale. Furthermore, substantial time for
audience participation is an integral com-
ponent ofthe program. Over the years we
have learned that this format facilitates an
open discussion that entails the presenta-
tion of a full range of views leading to a
more thorough understanding of the issue
at hand. Often an individual debater may
speak to an issue in which he or she has an
extensive record of publication; however,
this is not always the case. The prime
objective is to select debaters who will
develop strong arguments for the side they
are taking in a fashion analogous to an
attorney making the best argument for his
or her client.
Contrary to Lucier's editorial (1), this
format not only permits, but indeed
demands, full consideration of all relevant
data sets. The scientific expertise of the
chosen debaters plus the public nature of
the debate, combined with ample time for
both questions and comments from the
audience, ensures that this occurs. It is not
a simple case of choosing between two
opposite poles. Experience has demonstrat-
ed the scientific value of the debate. It
serves to enhance critical, constructive
thinking concerning the issue at hand.
Typically, this session draws a packed
room and, judging by the attentiveness of
the audience and their enthusiastic partici-
pation in the discussion, it is a highly val-
ued component ofour annual meeting.
We welcome more open dialog on the
value ofthis and other specific components
of the SOT annual meeting program,
which is intended to provide an interna-
tional forum for discussion of important
and sometimes controversial issues related
to the science oftoxicology.
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"Why Not Use It All?":
Another View
I join enthusiastically in Lucier'swell crafted
editorial argument (1) that full assessment
of the carcinogenic potential of chemical
compounds requires examination of epi-
demiologic, toxicologic, and mechanistic
data. To ignore information from any of
these three sources would be wasteful,
short-sighted, and not in the best interests
ofprotecting public health.
There is, however, afourth dimension of
carcinogenic risk assessment that has not to
date received adequate consideration. This is
the developmental dimension. The young of
all mammalian species have exposures and
vulnerabilities to chemical carcinogens that
are qualitatively and quantitatively different
from those ofadults. The special susceptibil-
ities of human babies were examined in
detail in the 1993 National Academy of
Sciences report Pesticides in the Diets of
InfantsandChildren (2).
The EPA Guidelines on Carcinogenic
Risk Assessment, on which Lucier com-
ments in his editorial (1), pay only scant
attention to developmental biology. The
current draft of these guidelines continues
to embody the outmoded fiction that the
entire American population can be repre-
sented by an adult white male who weighs
70 kg. Until our national policy on car-
cinogen risk assessment moves beyond this
limiting assumption and begins to require
explicit consideration of pediatric expo-
sures and risks, there will be little incentive
for researchers to explore pathways of
exposure, patterns of disease, or mecha-
nisms of carcinogenesis in the young. We
are not yet usingall ofthe data.
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Air Toxics Concentrations of
Methyl Chloride
On behalfofthe Methyl Chloride Industry
Association (MCIA; which comprises the
following domestic producers of methyl
chloride: Dow Chemical Company, Dow
Corning Corporation, General Electric
Company, and Vulcan Materials
Company), I would like to alert you to cer-
tain incorrect statements concerning methyl
chloride contained in "Public Health
Implications of 1990 Air Toxics
Concentrations across the United States"
(1). In this letter, I will briefly summarize
these incorrect statements and provide a
A 546 Volume 107, Number 1 1, November 1999 * Environmental Health Perspectives